El TDAH en el momento actualcontroversias, divergencias y convergencias

Referencias bibliográficas

• ANGOLD, A; ERKANLI, A; EGGER H; COSTELLO, E. J (2000). Stimulant Treatment for Children: A community Perspective, J. Am. Acad. Child Adolesc. Psychiatry, 39; 8: 975-994.
• BARKLEY, R. A (1997). Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHA. Psychol Bul, 121: 65-94.
• BARKLEY, R. A (1998). Handbook of Attention-Deficit/ Hyperactivity Disorder: A handbook for diagnosis and treatment (2nd Ed.), New York, Guilford Press.
• BARKLEY, R. A (2002). International consensus statement on ADHD. Clin Child Fam Psychol Rev, 5, 89-111.
• BARKLEY, R. A (2004). Adolescents with attentiondeficit/ hyperactivity disorder: an overview of empirically based treatments, J Psychiatr Pract, 10:39.
• BARKLEY, R. A (2007). Conferencia-Seminario en XLII Reunión Científica de AEPIJ. Bilbao, 2 de junio.
• BIEDERMAN, J (2005). Attention-Deficit/Hiperactivity Disorder: A selective overview. Biol Psychiatry, 57, 1215-1220.
• BIEDERMAN, J; FARAONE, S. V (2005). Attention-deficit hyperactivity disorder. Lancet, 366, 237-48. BIEDERMAN, J; FARAONE, S. V; LAPEY, K (1992). Comorbidity of diagnosis in attention-deficit disorder. En: Attention-Deficit Hyperactivity Disorder, Ed: Weiss G., Philadelphia, WB Saunders.
• BROWN, T. E (2000). Attention-Deficit Disorders and Comorbidities in Children, Adolescents and Adults, Washington D.C., American Psychiatric Press, Inc, 2000. Traducción española: Trastornos por déficit de atención y comorbilidades en niños adolescents y adultos. Barcelona, Masson, 2003.
• DOUBLE, D (2002).The limits of psychiatry, BMJ, 324, 900-904.
• GILLBERG, C. H; RASMUSSEN, P; CARLSTRÖM, G; SVENSON, B Y WALDESTRÖN, E (1982). Perceptual Motor and Attentional deficit in Six-year-Old Children, J. Child Psychol. Psychiat. 23 (2), 131-144.
• JENSEN, P. S (1999). Are Stimulants Overprescribed?, J. Am. Acad. Child Adolesc. Psychiatry, 38, 7, 797-804.
• JENSEN, P. S (2000). The NIH ADHD Consensus Statement: Win, Lose or Draw, J. Am. Acad. Child Adolesc. Psychiatry, 39, 2, 194-197.
• JENSEN, P. S ; MRAZEK D. A; KNAPP, P; STEINBERG, L; PFEFFER, C; SCHOWALTER, J; SHAPIRO, T (1997). Evolution and Revolution in Child Psychiatry:ADHD as a Disorder of Adaptation. Journal of the American Academy of child psychiatry J. Am. Acad. Child Adolesc. Psychiatry, 36, 12, 1672-1679.
• JENSEN, P. S; KNAPP, P; MRAZEK D. A (2006). Toward a New Diagnostic System for Child Psychopathology: Moving beyond the DSM. New York: Guildford Press.
• LASA ZULUETA, A (2001). Hiperactividad y trastornos de la personalidad: I. Sobre la hiperactividad, Cuadernos de Psiquiatría y Psicoterapia del Niño y del Adolescente, 31-32, 5-81.
• LASA ZULUETA, A (2003). Hiperactividad y trastornos de la personalidad: II. Sobre la personalidad límite, Cuadernos de Psiquiatría y Psicoterapia del Niño y del Adolescente, 35-36, 5-117.
• LEFEVER, G; SAWSON, K. V. D; MORROW, A. L (1999). The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools, Am J Public Health, 89, 1359-1364.
• MANZANO, J (2007). La part des neurosciences dans les constructions psychanalytiques. L´exemple du développement précoce, Revue Française de Psychanalyse, 71, Núm. 2. Neurosciences et psychanalyse.
• MTA COOPERATIVE GROUP (1999). A 14-month randomized clinical trial of treatement strategies for attention- deficit/hyperactivity disorder. Multimodal treatment study of children with ADHD. Arch Gen Psychiatry, 56, 1073-86.
• MTA COOPERATIVE GROUP (2004). National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics, 113, 762-69.
• MTA COOPERATIVE GROUP (2004). National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics, 113, 754-61.
• NATIONAL INSTITUTES OF HEALTH CONSENSUS DEVELOPMENT CONFERENCE STATEMENT: Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). NIH ADHD Consensus Statement 1998; 16; 1-37 y J. Am. Acad. Child Adolesc. Psychiatry, 2000; 39,2, 182-193.
• SAFER, D; ZITO, J; FINE, E (1996). Increased methylphenidate usage for attention deficit hyperactivity disorder in the 1990s. Pediatrics, 98, 1084-1088.
• SKODOL, A. E; OLDHAM, J. M (1996). Phenomenology, differential diagnosis and comorbidity of the impulsive-compulsive spectrum of disorders. En: Impulsivity and Compulsivity. Ed: Oldham J.M., Hollander E., Skodol A. E., Washington, American Psychiatric Press.
• SWANSON, J. M; SERGEANT, J. A; TAYLOR, E; SONUGABARKEE, E, J, S; JENSEN, P. S; CANTWELL, D. P (1998). Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet, 351, 429-33.
• VITIELLO, B; JENSEN, J (1997). Medication development and testing in children and adolescent. Arch Gen Psychiatry, 54, 871-876.
• ZITO, J. M; SAFER, D. J; DOS REIS, S; GARDNER J. F; BOLES, J; LYNCH, F (2000). Trends in prescribing of psychotropic medication in preschoolers. JAMA, 283, 1025-1030.